DRUG · Mapped RxNorm record
carboplatin
Normalized identity: carboplatinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
NCT00033553
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
gemcitabine hydrochloride
Normalized identity: gemcitabine hydrochlorideView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
paclitaxel
Normalized identity: paclitaxelView linked drug · Find medicine records ·
Find other trials using this name
RADIATION · Unmapped registry intervention
radiation therapy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCombination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
carboplatinDRUG · verified · RxNorm: carboplatin
gemcitabine hydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride
paclitaxelDRUG · verified · RxNorm: paclitaxel
radiation therapyRADIATION
Sponsors & collaborators
Alliance for Clinical Trials in Oncologylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
New YorkNew York, United States3ChicagoIllinois, United States3Washington D.C.District of Columbia, United States3St LouisMissouri, United States2San FranciscoCalifornia, United States2San DiegoCalifornia, United States2DurhamNorth Carolina, United States2MinneapolisMinnesota, United States2Las VegasNevada, United States2BuffaloNew York, United States2SyracuseNew York, United States2ColumbiaMissouri, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00033553 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.